◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Makers Laboratories Limited (MAKERSL) Financial History

Name: Makers Laboratories Limited (MAKERSL) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Makers Laboratories Limited (MAKERSL) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 114 employees. Its market capitalization is roughly ₹1 billion. In the fiscal year ended 2026-03-31, MAKERSL reported ₹1.4B in revenue and ₹24M in net income.

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing.

Interactive charts & full statements →

MAKERSL Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹1.4B	₹1.2B	₹1.0B	₹1.0B
Gross Profit	₹552M	₹460M	₹382M	₹390M
Operating Income (EBIT)	₹105M	₹42M	(₹32M)	(₹7M)
Net Income	₹24M	₹75M	(₹63M)	(₹48M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MAKERSL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹428M	₹358M	₹357M	₹342M	₹350M	—
Gross Profit	₹225M	₹209M	₹198M	₹183M	₹160M	—
Operating Income (EBIT)	₹58M	₹41M	₹30M	₹12M	₹19M	—
Net Income	₹15M	₹11M	₹9M	(₹1M)	₹4M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MAKERSL Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	—	—	(₹6M)	(₹6M)	(₹6M)

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MAKERSL Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹1.7B	₹1.5B	₹1.6B	₹1.5B	—
Total Liabilities	₹441M	₹328M	₹569M	₹426M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MAKERSL viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

1061 · Essex Bio-Technology Limited — HK$1 billion
ALPA · Alpa Laboratories Limited — ₹1 billion
KREBSBIO · Krebs Biochemicals & Industries Limited — ₹1 billion
VAISHALI · Vaishali Pharma Limited — ₹1 billion
GUD · Knight Therapeutics Inc. — C$1 billion
ESPR · Esperion Therapeutics, Inc. Common Stock — $819 million
0239 · Pak Fah Yeow International Limited — HK$773 million
COLL · Collegium Pharmaceutical, Inc. — $729 million

← MAK All “M” companies MAKO →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.